ArticleCancer research2017

Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer.

Jeffrey D Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.